✦ LIBER ✦

Phase II study of biweekly cetuximab in combination with irinotecan as second-line treatment in patients with platinum-resistant gastro-oesophageal cancer

✍ Scribed by K.R. Schønnemann; M. Yilmaz; J.K. Bjerregaard; K.M. Nielsen; P. Pfeiffer

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Biweekly cetuximab and irinotecan as sec

✍ Katrine R. Schoennemann; Jon K. Bjerregaard; Tine P. Hansen; Karin De Stricker; 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 200 KB

Phase II study of biweekly irinotecan an

✍ Yasuhide Yamada; Kuniaki Shirao; Ichinosuke Hyodo; Yasuaki Arai; Tadamichi Denda 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 190 KB

Oral Treosulfan as Second-Line Treatment

✍ Nina Keldsen; Ebbe Lindegaard Madsen; Hanne Havsteen; Claus Kamby; Lone Laursen; 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 55 KB

Phase II study of weekly irinotecan (CPT

✍ J. Cassinello; P. López-Alvarez; A. Martínez-Guisado; M. Valladares; G. Huidobro 📂 Article 📅 2003 🏛 Springer US 🌐 English ⚖ 106 KB

Α multicenter phase II study of pegylate

✍ Nikolaos Xenidis; Nikolaos Vardakis; Ioannis Varthalitis; Stylianos Giassas; Emm 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 205 KB

A phase II study testing weekly platinum

📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 141 KB